Nemesis82
liked
Good morning mooers! Here are things you need to know about today's Singapore:
●Singapore shares opened lower on Monday; STI down 1.01%
●Commodities face tough week as Fed angst builds
●Stocks and REITs to watch: Singtel, SPH Reit, Aspen
●Latest share buy back transactions
-moomoo News SG
Market Trend
Singapore shares opened lower on Monday. The $FTSE Singapore Straits Time Index (.STI.SG)$ decreased 1.01 per cent to 3,114.16 ...
●Singapore shares opened lower on Monday; STI down 1.01%
●Commodities face tough week as Fed angst builds
●Stocks and REITs to watch: Singtel, SPH Reit, Aspen
●Latest share buy back transactions
-moomoo News SG
Market Trend
Singapore shares opened lower on Monday. The $FTSE Singapore Straits Time Index (.STI.SG)$ decreased 1.01 per cent to 3,114.16 ...
1445
1387
Nemesis82
liked
Singapore real estate investment trusts can benefit from their safe-haven status during a time of market volatility as the U.S. Fed raises interest rates, analysts from DBS say in a research note.
The Fed's clarity on its rate-rise trajectory will likely lead to more price stability for Singapore REITs, they say.
What are Real Estate Investment Trusts (REITs)?
Real Estate Investment Trusts (REITs) are funds that invest in a port...
The Fed's clarity on its rate-rise trajectory will likely lead to more price stability for Singapore REITs, they say.
What are Real Estate Investment Trusts (REITs)?
Real Estate Investment Trusts (REITs) are funds that invest in a port...
1537
1277
Nemesis82
liked
$DiDi Global (Delisted) (DIDI.US)$第一次感到深深的绝望
10
2
Nemesis82
liked
$DiDi Global (Delisted) (DIDI.US)$ since it will delist nobody is interested in buying. only selling Pressure. $6 calls can fuck off
5
2
Nemesis82
liked
JPMorgan Chase & Co's Long Position in Angang Steel Preparation to 6.40% on Oct 4 from 7.52% - HKEX Filing
Hong Kong Stock Exchange documents: On October 4, J.P. Morgan Chase's long position in Angang Steel declined from 7.52% to 6.40%.
$Angang Steel (000898.SZ)$
$ANGANG STEEL (00347.HK)$
Hong Kong Stock Exchange documents: On October 4, J.P. Morgan Chase's long position in Angang Steel declined from 7.52% to 6.40%.
$Angang Steel (000898.SZ)$
$ANGANG STEEL (00347.HK)$
Translated
2
Nemesis82
liked
$Johnson & Johnson (JNJ.US)$ $SINOPHARM (01099.HK)$ COVID-19 vaccines from U.S. drugmaker Johnson & Johnson and China's Sinopharm as well as Russia's Sputnik V shot had no neutralizing activity against the Omicron variant, according to a study which has not yet been peer reviewed.
The Omicron variant has raised concerns regarding its ability to evade protection provided by widely-used vaccines, with drugmakers tailoring their shots to target the variant while testing the effectiveness of their existing shots.
Vaccines from $Moderna (MRNA.US)$ , $ASTRAZENECA PLC (AZNCF.US)$ and $Pfizer (PFE.US)$ and partner $BioNTech (BNTX.US)$ retained activity against Omicron, but the antibody response was greatly reduced when compared with the original virus strain first detected in China, the study found.
The study also found that while the effectiveness of $GlaxoSmithKline (GSK.US)$ and Vir Biotech's COVID-19 drug sotrovimab reduced three-fold against Omicron compared to the original strain, monoclonal antibody treatments by Regeneron and Eli Lilly completely lost their neutralizing activity against the variant.
The finding is consistent with recent laboratory tests demonstrating the two treatments lose most of their effectiveness when exposed to the Omicron variant.
The Omicron variant has raised concerns regarding its ability to evade protection provided by widely-used vaccines, with drugmakers tailoring their shots to target the variant while testing the effectiveness of their existing shots.
Vaccines from $Moderna (MRNA.US)$ , $ASTRAZENECA PLC (AZNCF.US)$ and $Pfizer (PFE.US)$ and partner $BioNTech (BNTX.US)$ retained activity against Omicron, but the antibody response was greatly reduced when compared with the original virus strain first detected in China, the study found.
The study also found that while the effectiveness of $GlaxoSmithKline (GSK.US)$ and Vir Biotech's COVID-19 drug sotrovimab reduced three-fold against Omicron compared to the original strain, monoclonal antibody treatments by Regeneron and Eli Lilly completely lost their neutralizing activity against the variant.
The finding is consistent with recent laboratory tests demonstrating the two treatments lose most of their effectiveness when exposed to the Omicron variant.
33
4
Nemesis82
liked
$XIAOMI-W (01810.HK)$ Is there a possibility of returning to 20?
Translated
6
2